Skip to main
TRNS
TRNS logo

Transcat (TRNS) Stock Forecast & Price Target

Transcat (TRNS) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 75%
Buy 0%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Transcat Inc. has shown a positive financial outlook driven by anticipated revenue growth and the expansion of gross margins within its Service segment, which constitutes the majority of the company's revenue. The company’s strong brand portfolio, including recognized names such as Extech and FLIR, suggests significant demand and market presence in the calibration and laboratory instrument services sector. Additionally, the belief that a premium valuation is warranted reflects investor confidence in Transcat as a profitable entity, likely to attract interest due to its revenue and earnings visibility.

Bears say

Transcat Inc. faces several significant risks that contribute to a negative outlook on its stock, including dilution risk linked to potential future capital raises and high customer concentration which may expose the company to revenue volatility. The firm is also challenged by heightened competition from web-based retailers in its distribution segment, which could adversely impact sales performance and market share. Additionally, share volatility driven by the company’s small capitalization and low liquidity could further deter investors, compounding the financial uncertainties surrounding the company's prospects.

Transcat (TRNS) has been analyzed by 4 analysts, with a consensus rating of Buy. 75% of analysts recommend a Strong Buy, 0% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Transcat and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Transcat (TRNS) Forecast

Analysts have given Transcat (TRNS) a Buy based on their latest research and market trends.

According to 4 analysts, Transcat (TRNS) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $107.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $107.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Transcat (TRNS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.